The V-myc Oncogene
Overview
Affiliations
v-myc is the viral homolog of c-myc transduced by several acute transforming retroviruses, many of which encode this gene as a Gag-Myc fusion protein. The v-myc oncogene can transform several lineages of mammalian and avian cells either alone or in cooperation with other oncogenes. While the Gag portion of the Gag-Myc fusion protein and the nuclear localization signal each appear to be dispensable for transformation, the N- and C-termini of the Myc sequence have been found to be essential for transformation. All v-myc genes contain point mutations which seem to confer a greater potency to v-myc in the process of transformation, proliferation, and apoptosis. In v-myc-transformed myelomonocytic cells, secondary events occur, such as the expression of colony stimulating factor-1 (CSF-1) which play a critical role in immortalization and subsequent tumor progression. Inhibition of the autocrine loop of CSF-1 was found to induce apoptosis in the immortalized cells. While overexpression of v-Myc blocks terminal differentiation of hematopoietic cells, this is not sufficient to block the differentiation of certain neural and skeletal muscle cells. Recent developments on the effects of v-myc on cell growth, transformation, differentiation and apoptosis are discussed in this review.
Identification of MYC intron 2 regions that modulate expression.
Tompkins V, Xue Z, Peterson J, Rouse W, OLeary C, Moss W PLoS One. 2024; 19(1):e0296889.
PMID: 38236931 PMC: 10795982. DOI: 10.1371/journal.pone.0296889.
Yazdani M Mol Neurobiol. 2024; 61(8):5665-5679.
PMID: 38224444 DOI: 10.1007/s12035-024-03938-7.
Significant position of C-myc in colorectal cancer: a promising therapeutic target.
Tan L, Peng D, Cheng Y Clin Transl Oncol. 2022; 24(12):2295-2304.
PMID: 35972682 DOI: 10.1007/s12094-022-02910-y.
Regulation of Nucleolar Activity by MYC.
Brown I, Lafita-Navarro M, Conacci-Sorrell M Cells. 2022; 11(3).
PMID: 35159381 PMC: 8834138. DOI: 10.3390/cells11030574.
Spera I, Sanchez-Rodriguez R, Favia M, Menga A, Venegas F, Angioni R Cancers (Basel). 2021; 13(21).
PMID: 34771641 PMC: 8582589. DOI: 10.3390/cancers13215478.